Risk factors for haemorrhage in patients with haematological malignancies
<p>Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 10<sup>9</sup>/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period...
Main Author: | Estcourt, LJ |
---|---|
Other Authors: | Murphy, MF |
Format: | Thesis |
Language: | English |
Published: |
2014
|
Subjects: |
Similar Items
-
Loss of chaperone protein in human cancer
by: Adighibe, O
Published: (2012) -
The emergence and early fate decisions of stem and progenitor cells in the haematopoietic system
by: Lutteropp, M
Published: (2012) -
Targeting hypoxia in solid and haematological malignancies
by: Bill Harris, et al.
Published: (2022-11-01) -
Characterising the cell biology of leukemic stem cells in acute myeloid leukemia.
by: Cornforth, TV
Published: (2013) -
The role of Notch and GATA3 in postnatal and adult haematopoiesis
by: Duarte, S
Published: (2011)